REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
14/11/2025
Voltar para busca
Dado oficial do USPTO
QI XING
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
65
Atualização mais recente
15/11/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
23/08/2004
Data de registro
14/11/2006
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/05/2017
Última transação
15/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
CN
Examinador
MATTHEWS, AMOS
Unidade examinadora
M80
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD.
Guangzhou Pharmaceutical Holdings Limited
Representantes
Jing Zhang IpHorgan Ltd.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines for the treatment of cardiovascular and cerebrovascular diseases and apoplexyhemiplegia and their sequela; Medicines for treatment of spontaneous and night sweating; Medicines for the treatment of menorrhagia or continuous uterine bleeding; Medicines for the treatment of the symptoms induced by asthenia of the kidneyfalling of the spleen to transport and convertdisorder of vital energy; Medicines for the treatment of gastrointestinal diseases; Medicines for treating respiratory disease and asthma; Medicines for the treatment of fever caused by febrile diseases; Medicines for the treatment of acute inflammationsfeverpyogenic infections; Medicines for the treatment of antitussive-cold; Medicines for the treatment of infectious diseases; Medicines for the treatment of bone diseases; Preparation for the relief of pain; Preparations for treating colds; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Dietetic foods adapted for medical use; Depurative for body; Fillings for teeth; Radioactive sources and standards for use in nuclear medicine; Gases for medical use; Sanitary sterilizing preparations; Contact lens solutions; Sanitary pads or incontinence pads; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; cultures of microorganisms for medical and veterinary use; food for babies
Publicações
Histórico de despachos e eventos da marca no USPTO.
65 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/06/2024
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/05/2017
71AG
REGISTERED-SEC.71 ACCEPTED
09/05/2017
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
27/04/2017
PR71
POST REGISTRATION ACTION MAILED - SEC.71
19/04/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/04/2017
ES71
TEAS SECTION 71 RECEIVED
02/11/2016
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
14/11/2015
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/10/2014
CHLD
CHANGE OF OWNER RECEIVED FROM IB
21/02/2014
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
29/05/2013
71AG
REGISTERED-SEC.71 ACCEPTED
29/05/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/05/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/05/2013
ES71
TEAS SECTION 71 RECEIVED
07/05/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/03/2008
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/06/2007
FIMP
FINAL DISPOSITION PROCESSED
21/06/2007
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/06/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
14/11/2006
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/10/2006
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/09/2006
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21/09/2006
PUBO
PUBLISHED FOR OPPOSITION
29/08/2006
NPUB
NOTICE OF PUBLICATION
09/08/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/07/2006
ALIE
ASSIGNED TO LIE
07/07/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/06/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/06/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2006
CNRT
NON-FINAL ACTION MAILED
01/05/2006
CNRT
NON-FINAL ACTION WRITTEN
01/05/2006
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/04/2006
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/04/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
13/03/2006
ALIE
ASSIGNED TO LIE
10/03/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/03/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/03/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/02/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/02/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/02/2006
CNRT
NON-FINAL ACTION MAILED
24/01/2006
CNRT
NON-FINAL ACTION WRITTEN
24/01/2006
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/01/2006
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/01/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/12/2005
ALIE
ASSIGNED TO LIE
02/12/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2005
CNEA
EXAMINERS AMENDMENT MAILED
01/12/2005
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/11/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/10/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/10/2005
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
31/10/2005
RFNT
REFUSAL PROCESSED BY IB
23/06/2005
CNRT
NON-FINAL ACTION MAILED
12/05/2005
CNRT
NON-FINAL ACTION WRITTEN
10/05/2005
DOCK
ASSIGNED TO EXAMINER
22/04/2005
NWAP
NEW APPLICATION ENTERED
22/04/2005
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/04/2005
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QI XING ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.